Tradestie Institutional Equity Comparison Engine

CODX vs GNPX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CODX Overall Edge

CODX Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Co-Diagnostics, Inc. Common Stock (CODX) driven by superior Valuation, Growth & Margin, Options & Structure while GNPX counters with relative strength in Momentum & Technical. Fundamentally, CODX trades at 15.4x Forward P/E with -3415.8% operating margin (+94.6% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CODX sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CODX
CODX 15.4x vs GNPX N/M Fwd P/E
Growth & Margin Winner CODX
Op Margin -3415.8% vs 0.0% ยท YoY +94.6% vs +0.0%
Momentum & Technical Winner GNPX
1Y -66.2% vs -56.6% ยท 52W Pos 0% vs 11%
Options & Structure Winner CODX
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
CODX NASDAQ
Co-Diagnostics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.13
-21.32% 1D
Market Cap $1.5M
1M Return -77.28%
1Y Return -66.21%
Forward P/E 15.4x
Unified AI Score
42.7 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 66.0 Mom 55.0
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CODX -66.21% GNPX -56.59% Spread: +5.58 pp (GNPX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CODX TTM Op. Margin: -3415.8% GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CODX vs GNPX. Trailing 12-month operating profitability (CODX -3415.8% vs GNPX 0.0%) and valuation multiples (CODX 15.4x vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CODX (5) vs GNPX (3)
Institutional Metric CODX GNPX Criterion Row Winner
Market Capitalization Scale $1.5M $2.2M Larger Scale Tie
Trailing P/E Ratio Valuation 15.4x N/M Lower Multiple CODX
Forward P/E Ratio Valuation 15.4x N/M Lower Multiple CODX
Revenue Growth (YoY) Growth +94.6% +0.0% Higher Growth CODX
Operating Margin (TTM) Profitability -3415.8% 0.0% Higher Margin GNPX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -192.8% -233.7% Higher ROE CODX
52-Week Range Position Momentum 0% ($0โ€“$14) 11% ($0โ€“$10) Stronger Trend GNPX
Beta / 30D Volatility Risk Regime 3.34ฮฒ ยท 162% Vol -4.68ฮฒ ยท 96% Vol Lower Realized Risk GNPX
Unified Institutional Score Composite Signal 42.7 / 100 (HOLD) 42.2 / 100 (HOLD) Higher Composite CODX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CODX vs GNPX Buy Guide
CODX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CODX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CODX nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.